NRX Pharmaceuticals annual depreciation and amortization
2020
2021
2022
2023
2024
2025
NRX Pharmaceuticals Depreciation & Amortization Growth & History (NRXP)
NRX Pharmaceuticals's depreciation and amortization was $70,000 for fiscal 2025.
View full NRX Pharmaceuticals company overviewNRX Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $70,000 | $65,000 | +1300.00% |
| 2024 | 2024-12-31 | $5,000 | $0 | 0.00% |
| 2023 | 2023-12-31 | $5,000 | $1,000 | +25.00% |
| 2022 | 2022-12-31 | $4,000 | $2,000 | +100.00% |
| 2021 | 2021-12-31 | $2,000 | $0 | 0.00% |
| 2020 | 2020-12-31 | $2,000 | — | — |
NRX Pharmaceuticals quarterly depreciation and amortization
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $66,000 | $66,000 | — |
| Q1 2026 | 2026-03-31 | $63,000 | $62,000 | +6200.00% |
| Q4 2025 | 2025-12-31 | $100,000 | — | — |
| Q3 2025 | 2025-09-30 | $26,000 | $24,000 | +1200.00% |
| Q2 2025 | 2025-06-30 | $0 | −$1,000 | — |
| Q1 2025 | 2025-03-31 | $1,000 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $2,000 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $1,000 | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $1,000 | $0 | 0.00% |
| Q3 2023 | 2023-09-30 | $2,000 | $1,000 | +100.00% |
| Q2 2023 | 2023-06-30 | $1,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $1,000 | $0 | 0.00% |
| Q3 2022 | 2022-09-30 | $1,000 | $0 | 0.00% |
| Q2 2022 | 2022-06-30 | $1,000 | — | — |
| Q1 2022 | 2022-03-31 | $1,000 | — | — |
| Q3 2021 | 2021-09-30 | $1,000 | — | — |
NRX Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, NRX Pharmaceuticals's depreciation and amortization increased from $2,000 to $70,000, a change of $68,000. The latest reported quarter, Q2 2026, shows $66,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NRX Pharmaceuticals source filings ↗